Director gets 370,000 ParkerVision (PRKR) options for 2026 service

Rhea-AI Filing Summary

ParkerVision Inc. reported a stock option award to director Robert Greene Sterne. On January 22, 2026, he received an option to purchase 370,000 shares of common stock at an exercise price of $0.24 per share, expiring January 22, 2031.

The option is compensation for 2026 Board service and vests in two equal installments on July 22, 2026 and January 22, 2027. After this grant, Sterne beneficially owns 370,000 derivative securities directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STERNE ROBERT GREENE

(Last) (First) (Middle)

4446-1A HENDRICKS AVE SUITE 354

(Street)

JACKSONVILLE FL 32207

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PARKERVISION INC [ PRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$0.24	01/22/2026		A		370,000		(1)	01/22/2031	Common Stock	370,000	$0.24	370,000	D

Explanation of Responses:

1. Option is awarded as compensation for 2026 Board service. Option vests in two, equal bi-annual increments on July 22, 2026 and January 22, 2027.

	/s/Robert G Sterne	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ParkerVision (PRKR) report in this Form 4?

ParkerVision reported that director Robert Greene Sterne received an option to purchase 370,000 shares of common stock as compensation for 2026 Board service.

What is the exercise price of the ParkerVision (PRKR) options granted to Robert Greene Sterne?

The option granted to Robert Greene Sterne has an exercise price of $0.24 per share for ParkerVision common stock.

When do Robert Greene Sterne’s ParkerVision (PRKR) options vest?

The option vests in two equal bi-annual installments: half on July 22, 2026 and the remaining half on January 22, 2027.

When do the ParkerVision (PRKR) options granted to Robert Greene Sterne expire?

The option granted on January 22, 2026 has an expiration date of January 22, 2031, if not exercised earlier.

How many ParkerVision (PRKR) derivative securities does Robert Greene Sterne own after this transaction?

Following this grant, Robert Greene Sterne beneficially owns 370,000 derivative securities (stock options) directly.

Is the ParkerVision (PRKR) Form 4 transaction a purchase or a grant?

The Form 4 reports an award of stock options (transaction code A) to director Robert Greene Sterne as compensation for 2026 Board service, not an open-market purchase.